Thirty-eight children with Hodgkin’s disease have been treated over the past 8 yr with either intensive radiotherapy or combination chemotherapy (MOPP), depending on their initial stage. The median survival of the entire group of children has not yet been reached, as 63% are still alive, but it will be in excess of 58 mo. Median survivals by stage are as follows: stage I, greater than 46 mo; stage II, greater than 46 mo; stage III, 35 mo; and stage IV, 26.7 mo. Although the numbers of children are small, these results appear significantly superior to published reports utilizing less intensive radiotherapy and single-agent chemotherapy and suggest that intensive radiotherapy for localized disease and combination chemotherapy for advanced disease may, at present, be the preferred forms of therapy for Hodgkin’s disease in childhood.

This content is only available as a PDF.